Vesnarinone

维司力农

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameVesnarinone
Drug Alias Name维纳啉酮威那力农维斯纳力酮Arkin-ZOPC-8212
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsHeart FailureSarcoma, KaposiHIV Infections
Global Approved IndicationsHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1990/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOtsuka America Pharmaceutical Inc
Active IndicationsHeart Failure
Inactive IndicationsSarcoma, KaposiHIV Infections

Other Information

ATC CodeC01CE
Related LinksWikipediaKEGG